IMCR Immunocore Holdings plc
$32.60▼ -2.92%
Healthcare
Other
After hours
$32.60▲ +0.00%
Sep 11, 7:30 PM ET
Volume 313.5K
Avg Volume (10D) 337.4K
Key Metrics & Fundamentals
Market Cap
$1.68B
P/E Ratio
–
Div Yield
–%
52W Range
27.56 - 40.72
% vs 50 MA
-6.01%
% vs 200 MA
-0.22%
RSI-14
34.1
MACD Histogram
-0.5600
Beta (1Y vs SPY)
0.63
Free Cash Flow
$15.14M
Gross Rev
$115.93M
Gross Profit
$114.84M
EBITDA
$4.14M
COGS
$1.09M
Operating Exp
$117.84M
Operating Income
-$3.00M
EBIT
-$3.00M
Pretax Income
-$514,000
Net Income
-$808,000
EPS (Diluted)
-0.02
Price & Volume History
Loading chart…
Recent News
Immunocore to present at upcoming investor conferences
GlobeNewswire · Sep 1, 2026 11:00 AM
Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues
Zacks · Aug 7, 2026 5:27 PM
Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High?
Zacks · Aug 7, 2026 1:55 PM
How Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment Story
Simply Wall St. · Aug 7, 2026 8:15 AM
Immunocore Q2 Earnings Call Highlights
MarketBeat · Aug 6, 2026 7:04 PM
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ...
GuruFocus.com · Aug 6, 2026 7:02 PM
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Strong Kimtrak Growth and ...
GuruFocus.com · Aug 6, 2026 5:06 PM
Immunocore reports second quarter financial results and provides a business update
GlobeNewswire · Aug 6, 2026 11:00 AM
Immunocore to report second quarter 2026 financial results and host call on August 6, 2026
GlobeNewswire · Jul 30, 2026 11:00 AM
Is Immunocore Holdings (IMCR) Undervalued After Its Recent Share Price Rebound?
Simply Wall St. · Jul 9, 2026 3:11 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See IMCR's money flow as a full page
Social Sentiment
Avg +0.30 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.